DOCETAXEL IN COMBINATION WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE (TAC) VERSUS 5-FLUOROURACIL IN COMBINATION WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE (5 FAC) AS ADJUVANT TREATMENT OF BREAST CANCER PATIENTS: